After years of neglect, concerns over pain, how it is assessed and managed on a patient-by-patient basis have captured the attention of health care professionals and the public. There are a variety of issues that have acted to draw this attention, including the high prevalence of pain, continuing evidence that pain is undertreated and a growing awareness of the negative consequences of poor pain management.
Infusion pumps were first introduced in the 1960s. These devices ushered in a whole new standard of care. Doctors were able to control precisely the amount of medication given to many patients. The pumps operate by controlling the fluid flow through the intravenous tubing that runs through them. Precise dosage control has been beneficial in controlling the delivery of pain medication.
This report analyzes the world markets for ambulatory infusion pumps for pain management, focusing on the current and future markets for these devices. The report generally reviews the nature and direction of research, as well as future markets.
Market size and growth for ambulatory infusion pumps generally and for ambulatory infusion pumps in pain management indications are provided for the years 2004 to 2008 for three regions: the United States, Europe, and Asia.
Epidemiology of various types of pain and key related statistics such as costs and surgery volume are also provided. This briefing also profiles several companies involved in marketing or developing such products in the field, including Alaris Medical Systems, I-Flow, Deltec, and Sgarlato Laboratories.
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. This information is also weighted with the projected timing and the probability of receiving FDA and other regulatory approval to market products. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians, researchers and public health officials.